Sorrento secures Brazil clearance to start Phase IIa long Covid trial
The trial will assess the safety and efficacy of up to three intravenous doses of COVI-MSC administered on alternate days.
Infectious Diseases
Latest in
Infectious Diseases
Resverlogix starts Phase IIb oral Covid-19 drug trial
The trial to assess the efficacy and safety of apabetalone will enrol 100 subjects at centres in Canada and Brazil.
Pipeline Moves: J&J ends ulcerative colitis trial, further study chances drop
Clinical Trials Arena reviews a total of six trials, including ones in gram-negative bacterial infections, hepatitis B, and obesity.
By
Moderna eyes combined Covid-19, flu booster by 2023
Moderna CEO Stéphane Bancel also said an Omicron-specific Covid-19 vaccine will enter clinical development in a matter of weeks.
By
HDT Bio dose first subjects in Phase I Covid-19 vaccine trial
The trial will enrol 90 subjects to assess the safety, tolerability, and immunogenicity of three dose levels of the vaccine.
Bod Australia to start long Covid-19 trial using medicinal cannabis in UK
The trial intends to enrol up to 30 subjects who are aged over 18 years with long Covid-19.
Ocugen-Bharat Biotech’s booster shot neutralises Omicron and Delta variants
Against Omicron, Covaxin-boosted sera showed similar neutralisation activity as the mRNA vaccine-boosted sera.
Pipeline Moves: GSK’s likelihood of further study in tuberculosis rises
Stuart Therapeutics in dry eye disease and Vifor Pharma in beta thalassemia are also reviewed by Clinical Trials Arena.
By